TERN-201 NASH clinical trial : Terns reports positive results for phase 1 study
TERN-201 NASH clinical trial : Terns Pharmaceuticals said that an ongoing phase 1 trial of its semicarbazide-sensitive amine oxidase (SSAO) inhibitor TERN-201 in non-alcoholic steatohepatitis ... Read More
LABORIE to acquire Clinical Innovations from EQT for $525m
LABORIE acquisition of Clinical Innovations : LABORIE Medical Technologies has agreed to acquire Utah-based Clinical Innovations for $525 million from EQT Mid Market US fund ... Read More
US Solar Fund to acquire 128MW Milford Solar Project from Longroad Energy
Solar acquisition news : US Solar Fund, a UK-based investment company, has signed an agreement to acquire the 128MW Milford Solar Project to be built ... Read More